Renaissance Technologies LLC Buys Shares of 41,699 National Health Investors, Inc. $NHI

Renaissance Technologies LLC bought a new position in National Health Investors, Inc. (NYSE:NHI) in the first quarter, Holdings Channel.com reports. The institutional investor bought 41,699 shares of the real estate investment trust’s stock, valued at approximately $3,372,000.

Other hedge funds have also modified their holdings of the company. Norges Bank purchased a new position in shares of National Health Investors in the 4th quarter worth approximately $55,301,000. Freestone Grove Partners LP purchased a new stake in National Health Investors during the fourth quarter valued at approximately $21,869,000. Adage Capital Partners GP L.L.C. acquired a new stake in National Health Investors in the fourth quarter valued at approximately $19,856,000. Balyasny Asset Management L.P. boosted its stake in National Health Investors by 66.9% in the second quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after acquiring an additional 246,486 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in National Health Investors by 481.3% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock worth $18,792,000 after purchasing an additional 195,716 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Up 0.0%

Shares of National Health Investors stock opened at $75.40 on Friday. The firm’s 50 day simple moving average is $75.13 and its two-hundred day simple moving average is $79.61. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 3.38 and a beta of 0.51. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

Insiders Place Their Bets

In other news, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction on Monday, June 15th. The stock was bought at an average price of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the company’s stock in a transaction on Friday, June 5th. The shares were purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the purchase, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

NHI has been the topic of a number of recent analyst reports. Zacks Research downgraded National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. BMO Capital Markets dropped their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Truist Financial reduced their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Finally, Wells Fargo & Company decreased their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.